Transcutaneous Spinal Stimulation for Blood Pressure in Spinal Cord Injury

((SCI) Trial)

LM
EE
Overseen ByEinat Engel-Haber, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Kessler Foundation
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to learn whether stimulation applied to the spinal cord through the skin (called transcutaneous spinal stimulation) can help control blood pressure in people with a spinal cord injury.

The main questions this study attempts to solve:

1. What are the immediate effects of spinal cord transcutaneous stimulation on BP?

2. Does stimulation produce lasting improvements in BP regulation and subsequently, daily function?

Who Is on the Research Team?

GF

Gail F Forrest, PhD

Principal Investigator

Kessler Foundation

Are You a Good Fit for This Trial?

This trial is for adults with spinal cord injury who have problems with low blood pressure or dizziness when standing up. People with certain heart, nerve, or spine conditions may also be eligible. Those with health issues that could make participation unsafe will not be included.

Inclusion Criteria

Individuals with a SCI ≥ 1 year after injury
I have ongoing low blood pressure below 90 mmHg.
I have symptoms when I stand up or need medicine for low blood pressure on standing.
See 3 more

Exclusion Criteria

Presence of cardiac pacemaker, defibrillator, or intra-cardiac lines
Pregnancy
I have had seizures in the past.
See 6 more

What Are the Treatments Tested in This Trial?

Interventions

  • Transcutaneous Spinal Stimulation

Trial Overview

Researchers are testing if a non-invasive treatment called transcutaneous spinal stimulation (applying mild electrical currents through the skin over the spine) can help control blood pressure in people with spinal cord injuries. The study includes tilt tests and multiple sessions of this stimulation.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: participants with chronic SCIs.Experimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Kessler Foundation

Lead Sponsor

Trials
190
Recruited
11,300+

Montclair State University

Collaborator

Trials
14
Recruited
1,200+